References
Bellomo R, Tip** P, Boyce N (1993) Continuous veno-venous hemoflltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21: 522–526
Bellomo R, Tip** P, Boyce N (1995) Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren Fail 17: 457–466
Hoffmann IN, Hard WH, Deppisch R, Faist E, Jochum M, Inthorn D (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22: 1360–1367
Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B (1997) Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 23: 288–296
Sander A, Armbruster W Sander B, Daul AE, Lange R, Peters J (1997) Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL6 and TNF alpha plasma concentrations. Intensive Care Med 23: 878–884
Van Bommel EF, Hesse CJ, Jutte NH, Zietse R, Bruining HA, Weimar W (1997) Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. Ren Fail 19: 443–454
Lonnemann G, Linnenweber S, Burg M, Koch KM (1998) Transfer of endogenous pyrogens across artificial membranes? Kidney Int Supp166:S43–S46
Hoffmann IN, Werdan K, Hard WH, Jochum M, Faist E, Inthorn D (1999) Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds. Shock 12:174–180
Riche F, Panis Y, Laisne MJ, Briard C, Cholley B, Bernard-Poenaru O, Graulet AM, Gueris J, Valleur P (1996) High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Surgery 120: 801–807
Van Dissel IT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M (1998) Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351: 950–953
Gogos CA, Drosou E, Bassaris HP, Skoutelis A (2000) Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181: 176–180
Waage A, Aasen AO (1992) Different role of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma. Immunol Rev 127:221–230
De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH (1999) Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephro 110:846–853
Hoffmann IN, Hard WH, Deppisch R, Faist E, Jochum M, Inthorn D (1995) Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 48:1563–1570
Tetta C, Mariano F, Buades J, Ronco C, Wratten ML, Camussi G (1997) Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. Am J Kidney Dis 30:S57–S65
Schetz M. Non-renal indications for continuous renal replacement therapy (1999) Kidney Int Supp 172:S88–S94
Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T (1989) The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169: 333–388
Van Deuren M (1998) Acute meningococcal disease. A study of clinical management, cytokine activation and regulation. Thesis, University of Nijmegen
Tetta C, Bellomo R, Brendolan A, Piccinni P, Digito A, Dan M, Irone M, Lonnemann G, Moscato D, Buades J, La Greca G, Ronco C (1999) Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill. Kidney Int Supp 172:S15–S19
Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P (1995) Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med 21:169–176
Silvester W (1997) Mediator removal with CRRT complement and cytokines. Am J Kidney Dis 30:S38–S43
Sieberth HG, Kierdorf HP (1999) Is cytokine removal by continuous hemofiltration feasible? Kidney Int Suppl 72:S79–S83
Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van Deuren, M., van der Meer, J. Hemofiltration in septic patients is not able to alter the plasma concentration of cytokines therapeutically. Intensive Care Med 26, 1176–1178 (2000). https://doi.org/10.1007/s001340000583
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001340000583